Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5798501 | 0.89 | HDAC6 (0.46) | HDAC6NOX1MEN1ADRA2AADRA2B | |
| SCHEMBL20291135 | 0.89 | HDAC6 (0.38) | HDAC6NOX1MEN1ADRA2ASLC6A2 | |
| SCHEMBL14934590 | 0.88 | CA12 (0.37) | HDAC6CA12CA9 | |
| SCHEMBL10331696 | 0.84 | HDAC6 (0.34) | HDAC6NOX1MEN1ADRA2AADRA2B | |
| SCHEMBL10331698 | 0.84 | HDAC6 (0.40) | HDAC6NOX1MEN1ADRA2AADRA2B | |
| SCHEMBL5796838 | 0.81 | HDAC6 (0.48) | HDAC6NOX1MEN1ADRA2AADRA2B | |
| SCHEMBL17278506 | 0.81 | HDAC6 (0.38) | HDAC6NOX1MEN1ADRA2AADRA2B | |
| SCHEMBL10331701 | 0.80 | HDAC6 (0.32) | HDAC6L3MBTL1 | |
| SCHEMBL14932219 | 0.80 | P2RX4 (0.38) | — | |
| SCHEMBL5795307 | 0.80 | HDAC6 (0.54) | HDAC6NOX1MEN1ADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12041848-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2024-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12041848-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, NR2E3 | HDAC6 3140/4885NOX1 460/4885MEN1 798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.